(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SUMITOVANT BIOPHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SUMITOVANT BIOPHARMA

ST13

US500000079283146

Class

5, 9, 35, 42, 44

Filing

79283146

Registration

6564625

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

09/09/2022

Trademark type

Word

Nice classes

5, 9, 35, 42, 44

Filing date

12/27/2019

Registration date

11/23/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/23/2021

Last transaction

11/23/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

ELTON, DAVID JONATHAN

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Sumitomo Pharma Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.

Representatives

Jeffrey Costellia NIXON PEABODY LLP

Technical classification

Nice Classes

Class 5Class 9Class 35Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsanti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous systemperipheral nervous systemcardiovascular systemendocrine systemmetabolic systemrenal systemgastroenterological systemophthalmologic system; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseasespsychiatric disorders and diseasesallergic disorders and diseases and disorders and diseases of the immune systemconnective tissue and joints; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparation for use in chemotherapy; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for hereditary diseases; pharmaceutical diagnostic preparations for medical purposes; pharmaceutical diagnostic reagents for medical use; biologic preparations for medical and therapeutic purposesvaccines; biologic preparations for medical and therapeutic purposescells for medical or clinical use; biologic preparations for medical and therapeutic purposesnucleic acid sequences for medical purposes

Class 9

Calculating machines; data processing apparatus; computers; computer hardware; computer peripherals; Downloadable computer software for providinganalyzing and generating reports; downloadable computer software and programs for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and/or transmission of dataimages and information; downloadable computer software and programs for the conversionanalysisprocessingstorage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for accessing and providing updated scientificmedicalpharmaceutical and clinical informationnews information of general interest; downloadable computer software for accessingcontrolling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuringmonitoringprocessing and tracking healthwellness and medical information; downloadable computer software for use with medical patient monitoring equipmentfor receivingprocessingtransmitting and displaying data; downloadable computer software for analytics in the fields of public healthhealthcarebiomedical research; downloadable computer software for analytics for clinical trial data

Class 35

Advertising; publicity agency services; business management; business management assistance; business administration; business consulting services; secretarial services; providing office functions; business research; providing business information; marketing research; market analysis services; provision of market research information; marketing services; compiling of information into computer databases; updating and maintenance of data in computer databases; business data analysis; assistanceadvisory services and consultancy with regard to business analysisin the field of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis; statistical analysis and reporting in the field of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis and reporting services for business purposes in the fields of healthcare databiomedical and pharmaceutical research and clinical trial data; business analysis in the field of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; systematization of data in computer databases

Class 42

technical consultancy relating to technical and scientific analysis in the fields of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; medical research; chemistry servicesresearch in the field of chemistry; clinical trialsconducting clinical trials for others; analysis of technical datadata analytics in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services; testinginspection or scientific research of pharmaceuticalscosmetics or foodstuffs; providing medical and scientific research information relating to clinical trials of pharmaceuticals; medical and scientific research in the field of pharmaceutical and biologic therapeutic products; providing information relating to testinginspection or medical and scientific research of pharmaceuticals; cloud computing featuring software for use in database management in the field of healthcarepharmaceuticalsbiomedicineclinical trialpost-market trial data; provision of scientific and technological information and data relating to scientific and technological research and development in the fields of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; rental of computers; providing temporary use of online non-downloadable computer programs on data networks containing databases of pharmaceutical productsmedical informationclinical trial data as well as data from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; software as a service SaaS featuring software for providing information online in the fields of biomedical research and clinical trials from a computer database or the Internet; computer software designcomputer programmingmaintenance of computer software

Class 44

Provision of medical information; providing health information; providing medical information from a web site; providing healthcare information from a web site; health counseling; provision of medical information relating to pharmaceutical and biologic therapeutic products

Publications

History of USPTO decisions and trademark events.

39 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/09/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/30/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/10/2022

FIMP

FINAL DISPOSITION PROCESSED

05/10/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/23/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/23/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/07/2021

PUBO

PUBLISHED FOR OPPOSITION

09/07/2021

GPNX

NOTIFICATION PROCESSED BY IB

09/05/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/18/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/18/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/18/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/30/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

07/30/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/30/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

07/30/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/30/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/13/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/13/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/13/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/10/2021

GNFR

FINAL REFUSAL E-MAILED

03/10/2021

CNFR

FINAL REFUSAL WRITTEN

03/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/03/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/03/2021

ALIE

ASSIGNED TO LIE

02/03/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/27/2020

ATRV

ATTORNEY REVIEW COMPLETED

07/08/2020

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

07/01/2020

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

06/26/2020

RFNT

REFUSAL PROCESSED BY IB

05/15/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/28/2020

RFRR

REFUSAL PROCESSED BY MPU

04/28/2020

MAFR

APPLICATION FILING RECEIPT MAILED

04/17/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/15/2020

CNRT

NON-FINAL ACTION WRITTEN

04/14/2020

DOCK

ASSIGNED TO EXAMINER

04/13/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/13/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/09/2020

Continuous trademark protection

Get notified about every new filing that threatens SUMITOVANT BIOPHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.